Australian Authorities Warn of Counterfeit Rabies Vaccines in India: Travelers Urged to Seek Replacement Doses and Medical Advice

Image generated with Ai

Australian health authorities have issued an urgent travel alert following the discovery of counterfeit batches of the Abhayrab rabies vaccine circulating in India. This alarming development has raised concerns for travelers who may have received fake doses, putting them at risk of exposure to the deadly rabies virus without any real protection.

The warning, issued by the Australian Technical Advisory Group on Immunisation (ATAGI) and local health departments, specifically targets travelers who received the rabies vaccine in India after November 1, 2023. Health officials are urging those vaccinated during this period to seek immediate medical advice due to the potential ineffectiveness of the counterfeit vaccine.

What Travelers Need to Know About the Fake Rabies Vaccine

The problem was first identified in early 2025, when the vaccine’s manufacturer, Indian Immunologicals Limited, discovered counterfeit Abhayrab vials in the market. Investigations revealed that the fake vaccines were being sold with genuine batch numbers, making it difficult for both patients and healthcare providers to distinguish between real and fake products.

Abhayrab is a World Health Organization (WHO)-prequalified rabies vaccine used for both pre-exposure and post-exposure prevention of rabies. However, the counterfeit vaccines were found to contain significant differences in chemical composition, packaging, and labelling, which compromised their effectiveness. Experts warned that these fake vaccines might lack the active antigen required to offer protection, leaving vaccinated individuals vulnerable to rabies.

The Widespread Impact and Risk to International Travelers

Authorities have confirmed the presence of counterfeit vials in major Indian cities such as Delhi, Mumbai, Ahmedabad, and Lucknow. However, they have warned that the issue could be more widespread, and travelers who received Abhayrab vaccines in India from November 1, 2023, onward may be at serious risk.

Rabies is a fatal disease that attacks the central nervous system and is nearly always fatal once symptoms begin. Rabies is typically transmitted through bites or scratches from infected animals, such as dogs or monkeys. In India, these animals remain the primary carriers of the virus. If the counterfeit vaccine does not offer immunity, individuals vaccinated with these doses may be exposed to the virus and potentially face severe health consequences.

Immediate Action for Travelers to India

Given the gravity of the situation, Australian health authorities are advising anyone who received a rabies vaccination in India since November 1, 2023, to immediately seek medical guidance. Travelers who were vaccinated with Abhayrab or are unsure of the vaccine brand should consult with healthcare providers as soon as possible.

Replacement Doses of Approved Vaccines
Affected individuals are being strongly encouraged to receive replacement doses of Rabipur or Verorab, which are vaccines approved in Australia for effective rabies protection. These vaccines are known for their safety and reliability. Health authorities have stressed the importance of starting the replacement vaccination process immediately to ensure adequate protection against rabies.

Caution for Future Travelers to India

This alert also serves as a precautionary measure for those planning to travel to India in the future. Australian health officials recommend that travelers complete their rabies vaccinations before arriving in India, ensuring better protection against the disease and simplified treatment in case of exposure.

In addition to vaccination, travelers should exercise caution by avoiding contact with stray dogs, monkeys, and other mammals, which are the main sources of rabies transmission in India. High-risk areas include those where vaccination efforts are less effective, making it essential for travelers to follow safety guidelines closely.

The International Response to Counterfeit Rabies Vaccines

This travel alert follows similar investigations by health authorities in the United Kingdom and the United States, which also raised concerns about counterfeit rabies vaccines in India. In the UK, a rabies-related death was traced back to a traveler who had received a counterfeit vaccine in India, further amplifying the seriousness of the issue.

Economic and Health Consequences for India

The circulation of counterfeit vaccines presents serious public health risks and may also have long-term economic consequences for India’s medical tourism industry. India is a key global destination for medical tourism, and the credibility of its healthcare services could be impacted by concerns over the authenticity of vaccines and other medical products.

As international confidence in the safety of treatments in India is shaken, this situation could deter future visitors seeking medical care, thus affecting the country’s medical tourism sector, which relies heavily on trust and efficacy.

Conclusion: Protecting Public Health and Ensuring Safe Travel

The discovery of counterfeit rabies vaccines has raised serious concerns for the travel industry and the health sector alike. As health authorities continue to investigate and respond to the issue, it is crucial that affected individuals take swift action by seeking medical advice and receiving replacement vaccinations.

For travelers planning to visit India, taking steps to ensure vaccination prior to departure and remaining cautious of rabies exposure will provide added protection. Public health bodies in both Australia and India are working together to safeguard global health and ensure that medical products remain safe and trustworthy for international travelers.

This incident serves as an important reminder of the risks posed by counterfeit medical products and the need for continued vigilance in maintaining the integrity of life-saving vaccines. It also highlights the essential role of global cooperation to address such challenges and ensure the safety of travelers worldwide.